Cargando…

Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis

BACKGROUND: Central nervous system tuberculosis (CNS-TB) is the most devastating form of extrapulmonary tuberculosis. Rifampin (RIF) is a first-line antimicrobial agent with potent bactericidal action. Nonetheless, the blood-brain barrier (BBB) limits the therapeutic effects on CNS-TB. Exosomes, how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Han, Ding, Yinan, Huang, Jiayan, Zhao, Yanyan, Chen, Wei, Tang, Qiusha, An, Yanli, Chen, Rong, Hu, Chunmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888470/ https://www.ncbi.nlm.nih.gov/pubmed/36733407 http://dx.doi.org/10.2147/IJN.S395246

Ejemplares similares

Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
por: Habib, Saffiya, et al.
Publicado: (2022)

Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma
por: He, Chen, et al.
Publicado: (2021)

Homogeneous antibody–angiopep 2 conjugates for effective brain targeting
por: Anami, Yasuaki, et al.
Publicado: (2022)

Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates
por: Pethő, Lilla, et al.
Publicado: (2023)

Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
por: Wang, Xuan, et al.
Publicado: (2018)

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023)

A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles
por: Qiao, Lanxin, et al.
Publicado: (2020)

Protective Effect of Rifampicin Loaded by HPMA-PLA Nanopolymer on Macrophages Infected with Mycobacterium Tuberculosis
por: Yang, Guoping, et al.
Publicado: (2022)

LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo
por: He, Chen, et al.
Publicado: (2021)

Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
por: Wang, Xuan, et al.
Publicado: (2019)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM)
por: di Polidoro, Angela Costagliola, et al.
Publicado: (2022)

Facile assembly of upconversion nanoparticle-based micelles for active targeted dual-mode imaging in pancreatic cancer
por: Han, Yong, et al.
Publicado: (2018)

Role of Exosomes in Central Nervous System Diseases
por: Liu, Wanying, et al.
Publicado: (2019)

Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
por: Wang, Chengguang, et al.
Publicado: (2022)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy
por: Zong, Zhenkun, et al.
Publicado: (2019)

Central Nervous System Cell-Derived Exosomes in Neurodegenerative Diseases
por: Tian, Yang, et al.
Publicado: (2021)

Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
por: Ding, Yinan, et al.
Publicado: (2021)

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis
por: Marcianes, Patricia, et al.
Publicado: (2017)

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
por: Fan, Yishu, et al.
Publicado: (2022)

Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier
por: Papademetriou, Iason, et al.
Publicado: (2018)

Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin
por: Zhao, Yue, et al.
Publicado: (2020)

An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors
por: Parrasia, Sofia, et al.
Publicado: (2021)

Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Emerging Role of Neuronal Exosomes in the Central Nervous System
por: Chivet, Mathilde, et al.
Publicado: (2012)

Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
por: Fonseca, Adriana Aparecida Durães, et al.
Publicado: (2020)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021)

Retracted: Protective Effect of Rifampicin Loaded by HPMA-PLA Nanopolymer on Macrophages Infected with Mycobacterium Tuberculosis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles
por: Ge, Zhaohui, et al.
Publicado: (2018)

Central nervous system Listeria monocytogenes infection mimicking central nervous system idiopathic inflammatory demyelinating disease
por: Xu, Rui, et al.
Publicado: (2019)

The promise of exosome applications in treating central nervous system diseases
por: Mattingly, Jared, et al.
Publicado: (2021)

Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India
por: Desikan, Prabha, et al.
Publicado: (2023)

A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis
por: Patil, Jagadevappa S., et al.
Publicado: (2015)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
por: Zhou, Ruiyi, et al.
Publicado: (2022)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Rifampicin-induced nephrotoxicity in a tuberculosis patient
por: Beebe, Alexandria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gmg8qonjv43nkc58suq3tbl2t4